Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Mesh.i » - entrée « Humans »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Human Umbilical Vein Endothelial Cells < Humans < Hungary  Facettes :

List of bibliographic references indexed by Humans

Number of relevant bibliographic references: 2258.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000494 (2020) Naoto Sakumura [Japon] ; Hitoshi Irabu [Japon] ; Natsumi Inoue [Japon] ; Mao Mizuta [Japon] ; Masaki Shimizu [Japon]Clinical usefulness of longitudinal IL-6 monitoring in a patient with Takayasu aortitis receiving tocilizumab.
000521 (2020) Jon T. Giles [États-Unis] ; Naveed Sattar [Royaume-Uni] ; Sherine Gabriel [États-Unis] ; Paul M. Ridker [États-Unis] ; Steffen Gay [Suisse] ; Charles Warne [Royaume-Uni] ; David Musselman [États-Unis] ; Laura Brockwell [Royaume-Uni] ; Emma Shittu [Royaume-Uni] ; Micki Klearman [États-Unis] ; Thomas R. Fleming [États-Unis]Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial.
000544 (2020) Carina Mihai [Suisse] ; Rucsandra Dobrota [Suisse] ; Maria Schröder [Suisse] ; Alexandru Garaiman [Suisse] ; Suzana Jordan [Suisse] ; Mike Oliver Becker [Suisse] ; Britta Maurer [Suisse] ; Oliver Distler [Suisse]COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD.
000571 (2020) Seong-Kyu Kim ; Sang Gyu Kwak [Corée du Sud] ; Jung-Yoon ChoeAssociation between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry.
000582 (2020) Franco Maria Buonaguro [Italie] ; Igor Puzanov [États-Unis] ; Paolo Antonio Ascierto [Italie]Anti-IL6R role in treatment of COVID-19-related ARDS
000586 (2020) Tomohiro Koga ; Naoko Hagimori [Japon] ; Shuntaro Sato [Japon] ; Shinpei Morimoto [Japon] ; Naoki Hosogaya [Japon] ; Chizu Fukushima [Japon] ; Hiroshi Yamamoto [Japon] ; Atsushi KawakamiAn open-label continuation trial of tocilizumab for familial Mediterranean fever with colchicine ineffective or intolerance
000587 (2020) A. Ahmad [Arabie saoudite] ; M U Rehman ; K M AlkharfyAn alternative approach to minimize the risk of coronavirus (Covid-19) and similar infections.
000613 (2020) Bernhard Hellmich [Allemagne] ; Ana Agueda [Portugal] ; Sara Monti [Italie] ; Frank Buttgereit [Allemagne] ; Hubert De Boysson [France] ; Elisabeth Brouwer [Pays-Bas] ; Rebecca Cassie [Royaume-Uni] ; Maria C. Cid [Espagne] ; Bhaskar Dasgupta [Royaume-Uni] ; Christian Dejaco [Autriche] ; Gulen Hatemi [Turquie] ; Nicole Hollinger [Allemagne] ; Alfred Mahr [France] ; Susan P. Mollan [Royaume-Uni] ; Chetan Mukhtyar [Royaume-Uni] ; Cristina Ponte [Portugal] ; Carlo Salvarani [Italie] ; Rajappa Sivakumar [Inde] ; Xinping Tian [République populaire de Chine] ; Gunnar Tomasson [Islande] ; Carl Turesson [Suède] ; Wolfgang Schmidt [Allemagne] ; Peter M. Villiger [Suisse] ; Richard Watts [Royaume-Uni] ; Chris Young [Royaume-Uni] ; Raashid Ahmed Luqmani [Royaume-Uni]2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
000614 (2020) Haneul Kim [Corée du Sud] ; Seungye Baek [Corée du Sud] ; Seung-Min Hong [Corée du Sud] ; Jaeseon Lee [Corée du Sud] ; Seung Min Jung [Corée du Sud] ; Jennifer Lee [Corée du Sud] ; Mi-La Cho [Corée du Sud] ; Seung-Ki Kwok [Corée du Sud] ; Sung-Hwan Park [Corée du Sud]1,25-dihydroxy Vitamin D3 and Interleukin-6 Blockade Synergistically Regulate Rheumatoid Arthritis by Suppressing Interleukin-17 Production and Osteoclastogenesis
000624 (2019) Larisa Shelikhova [Russie] ; Maria Ilushina [Russie] ; Zhanna Shekhovtsova [Russie] ; Daria Shasheleva [Russie] ; Rimma Khismatullina [Russie] ; Elena Kurnikova [Russie] ; Dmitriy Pershin [Russie] ; Dmitriy Balashov [Russie] ; Svetlana Radygina [Russie] ; Pavel Trakhtman [Russie] ; Irina Kalinina [Russie] ; Yakov Muzalevskii [Russie] ; Alexei Kazachenok [Russie] ; Viktoria Zaharova [Russie] ; Varvara Brilliantova [Russie] ; Yulia Olshanskaya [Russie] ; Agnesa Panferova [Russie] ; Elena Zerkalenkova [Russie] ; Dina Baidildina [Russie] ; Galina Novichkova [Russie] ; Alexander Rumyantsev [Russie] ; Alexei Maschan [Russie] ; Michael Maschan [Russie]αβ T Cell-Depleted Haploidentical Hematopoietic Stem Cell Transplantation without Antithymocyte Globulin in Children with Chemorefractory Acute Myelogenous Leukemia.
000626 (2019) Claudia Dechant [Allemagne] ; Hendrik Schulze-Koops [Allemagne][Update Giant Cell Arteriitis].
000627 (2019) Maxime Samson [France] ; Hélène Greigert [France] ; Thibault Ghesquière [France] ; Bernard Bonnotte [France][Treatment of giant cell arteritis].
000628 (2019) F. Frikha [Tunisie] ; S. Garbaa [Tunisie] ; Y. Bouattour [Tunisie] ; M. Snoussi [Tunisie] ; H. Loukil [Tunisie] ; R. Ben Salah [Tunisie] ; Z. Bahloul [Tunisie][Tocilizumab for refractory Takayasu arteritis with aortic aneurysm].
000629 (2019) Zaira Cubiles Arillo [Espagne] ; Esmeralda Nú Ez Cuadros [Espagne] ; Ver Nica Martínez Rivera [Espagne] ; José Manuel González G Mez [Espagne] ; Victorio Cuenca Peir [Espagne][Takayasu arteritis of atypical presentation. Tocilizumab as an alternative therapeutic option].
000630 (2019) Sophie De Seigneux ; Belen Ponte ; Karine Hadaya ; Patrick Saudan[Nephrology : what's new in 2018 ?]
000631 (2019) P M Villiger [Suisse][Large-vessel vasculitis-giant cell and Takayasu arteritis].
000632 (2019) H. Liao [République populaire de Chine] ; L L Pan ; J. Du ; N. Gao ; T. Wang[Efficacy and safety of tocilizumab in patients with Takayasu arteritis].
000633 (2019) Y X Zuo [République populaire de Chine] ; Y P Jia [République populaire de Chine] ; J. Wu [République populaire de Chine] ; J B Wang [République populaire de Chine] ; A D Lu [République populaire de Chine] ; L J Dong [République populaire de Chine] ; L J Chang [République populaire de Chine] ; L P Zhang [République populaire de Chine][Chimeric antigen receptors T cells for treatment of 48 relapsed or refractory acute lymphoblastic leukemia children: long term follow-up outcomes].
000634 (2019) Ariane Klein [Allemagne][Biologics in the treatment of juvenile idiopathic arthritis : A comparison of mono- and combination therapy with synthetic DMARDs].
000643 (2019) C B Bunker [Royaume-Uni] ; J. Manson [Royaume-Uni]Vitiligo remitting with tocilizumab.
000645 (2019) Durga P. Misra [Inde] ; Godasi S R S N K. Naidu [Inde] ; Vikas Agarwal [Inde] ; Aman Sharma [Inde]Vasculitis research: Current trends and future perspectives.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Humans" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Humans" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Humans
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021